Centessa Pharmaceuticals plc Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Depreciation and Depletion 0.13M0.30M0.30M
Share-based Compensation 0.24M0.34M14.85M24.96M29.39M33.55M
Deferred Taxes -2.86M-26.53M2.65M
Gains from Investment Securities -0.21M9.71M
Cash from Operations -5.83M-10.63M-135.11M-200.55M-160.34M-142.06M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.01M0.03M0.13M0.81M0.94M
Change in Working Capital
Change in Account Payables 0.85M-0.05M4.16M6.35M-2.72M-4.58M
Change in Accured Expenses 0.12M0.65M12.97M6.26M-0.80M22.77M
Other Working Capital Changes 1.40M-0.31M16.16M3.73M-1.88M-10.22M
Investing Activities
Capital Expenditures 0.19M1.14M0.17M0.03M
Acquisitions 63.44M
Change in Acquisitions & Divestments 138.07M171.83M
Cash from Investing Activities 63.26M-0.93M-127.00M31.27M
Financing Activities
Other financing activities -0.29M-0.26M-5.32M
Cash from Financing Activities 9.01M1.36M660.15M0.46M21.12M364.75M
Additional items
Exchange Rate Effect 0.52M-0.07M1.82M-0.42M0.61M1.23M
Change in Cash 3.70M-9.34M590.12M-201.44M-265.61M255.19M
Beginning Cash Balance 0.28M
Free Cash Flow -5.83M-10.63M-135.29M-201.68M-160.51M-142.09M
Net Cash Flow 3.18M-9.27M588.29M-201.02M-266.23M253.96M